Etienne Sibille

      Co-Founder & Chief Scientific Officer

      Etienne Sibille, PhD, is Chief Scientific Officer and a co-founder of Damona Pharmaceuticals. A neuroscientist and neuropharmacologist, he is a Senior Scientist in the Campbell Family Mental Health Research Institute at the Centre for Addiction and Mental Health (CAMH) in Toronto, where he held the Campbell Family Chair in Clinical Neuroscience for 10 years. Dr. Sibille is also a professor in the Department of Psychiatry and the Department of Pharmacology and Toxicology at the University of Toronto.

      Dr. Sibille is deeply committed to translational research aimed at identifying the cellular and molecular bases of depression—specifically, in relation to mood, affect, and cognitive components of the illness—to develop novel therapeutic approaches.

      Dr. Sibille obtained a PhD from Cornell University followed by postdoctoral training at Columbia University. Prior to joining CAMH, he held academic faculty positions at both Columbia and the University of Pittsburgh.

      Etienne Sibille

      Etienne Sibille

      Co-Founder & Chief Scientific Officer

      Contact information